1. The author is in the Center for Bone Biology at the University of Pittsburgh Medical Center and the Myeloma Program of the University of Pittsburgh Cancer Institute, VA Pittsburgh Healthcare System, R & D 151U, University Drive C, Pittsburgh, Pennsylvania 15240, USA. e-mail: roodmangd@upmc.edu

Abstract

A drug used to counteract low white blood cell counts in individuals with breast cancer may also be inducing bone metastases (pages 26–27).

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NPG Journals

by Subject Area

• Chemistry

  • Chemistry
  • Drug discovery
  • Biotechnology
  • Materials
  • Methods & Protocols

• Clinical Practice & Research

  • Cancer
  • Cardiovascular medicine
  • Dentistry
  • Endocrinology
  • Gastroenterology & Hepatology
  • Methods & Protocols
  • Pathology & Pathobiology
  • Urology

• Earth & Environment

  • Earth sciences
  • Evolution & Ecology

• Life sciences

  • Biotechnology
  • Cancer
  • Development
  • Drug discovery
  • Evolution & Ecology
  • Genetics
  • Immunology
  • Medical research
  • Methods & Protocols
  • Microbiology
  • Molecular cell biology
  • Neuroscience
  • Pharmacology
  • Systems biology

• Physical sciences

  • Physics
  • Materials

by A - Z Index